Market Insights Health OTC Pharmaceuticals

Cold & Cough Remedies - Japan

Japan

In Japan, the revenue generated in the Cold & Cough Remedies market market in 2024 amounts to ¥€1.05bn.
It is projected that the market will experience an annual growth rate of 5.62% from 2024 to 2029 (CAGR 2024-2029).
When comparing the revenue on a global scale, the in the United States leads with a total revenue of €10,380.00m in 2024.
To put this into perspective, in Japan, the revenue per person in the Cold & Cough Remedies market market is ¥€8.58 in 2024.
Japanese consumers are increasingly turning to natural and traditional remedies for cold and cough, seeking a balance between modern medicine and traditional practices.

Key regions: Australia, Japan, India, Brazil, Canada

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Cold & Cough Remedies market in Japan has been experiencing steady growth in recent years.

Customer preferences: Japanese consumers have a strong preference for natural and traditional remedies for cold and cough symptoms. They often seek out products that contain herbal ingredients or are based on traditional Japanese medicine. This preference for natural remedies is driven by a cultural belief in the power of nature and a desire to avoid the potential side effects of synthetic drugs. Additionally, Japanese consumers tend to be health-conscious and proactive in managing their own health, which contributes to the demand for over-the-counter cold and cough remedies.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in Japan is the increasing demand for combination products. These products offer multiple benefits, such as relieving both cold and cough symptoms, and are convenient for consumers who prefer to purchase a single product to address multiple symptoms. Combination products also appeal to consumers who are looking for more holistic solutions to their health issues.Another trend in the market is the growing popularity of natural and herbal remedies. Japanese consumers are increasingly seeking out products that are made from natural ingredients and are free from artificial additives. This trend is driven by a desire for safer and more sustainable products, as well as a growing awareness of the potential health benefits of natural remedies.

Local special circumstances: The aging population in Japan is a significant factor driving the growth of the Cold & Cough Remedies market. As the population ages, there is a higher prevalence of cold and cough symptoms, leading to increased demand for remedies. Additionally, older consumers are more likely to seek out over-the-counter remedies rather than visiting a doctor, which further contributes to the growth of the market.Another special circumstance in Japan is the high level of health consciousness among consumers. Japanese consumers place a strong emphasis on preventive health measures and are proactive in managing their own health. This leads to a higher demand for cold and cough remedies as consumers seek to alleviate symptoms and prevent further illness.

Underlying macroeconomic factors: The strong economy in Japan has contributed to the growth of the Cold & Cough Remedies market. With a stable job market and rising disposable incomes, consumers have more purchasing power to spend on healthcare products. This includes over-the-counter remedies for cold and cough symptoms.Additionally, the COVID-19 pandemic has had an impact on the market. The increased focus on personal health and hygiene has led to a higher demand for cold and cough remedies as consumers seek to protect themselves from illness. The pandemic has also raised awareness about the importance of managing cold and cough symptoms to prevent the spread of respiratory diseases, further driving the demand for remedies.In conclusion, the Cold & Cough Remedies market in Japan is experiencing growth due to customer preferences for natural and traditional remedies, the increasing demand for combination products, the aging population, high health consciousness among consumers, a strong economy, and the impact of the COVID-19 pandemic.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.